Bourdel N, Chauvet P, Canis M
Service de gynécologie-obstétrique et reproduction humaine, CHU d'Estaing, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand, France; Faculté de médecine, Encov-ISIT (UMR6284 CNRS/université d'Auvergne), 28, place Henri-Dunant, 63000 Clermont-Ferrand, France.
Service de gynécologie-obstétrique et reproduction humaine, CHU d'Estaing, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand, France; Faculté de médecine, Encov-ISIT (UMR6284 CNRS/université d'Auvergne), 28, place Henri-Dunant, 63000 Clermont-Ferrand, France.
Gynecol Obstet Fertil Senol. 2018 Mar;46(3):209-213. doi: 10.1016/j.gofs.2018.02.008. Epub 2018 Mar 4.
In this chapter we have examined the possibilities of screening endometriosis, both in the general population as well as in the target population. We then proposed decision trees, for primary and secondary care. Currently, there is not enough data in the literature to develop or organize a screening test for endometriosis. Screening for endometriosis is not recommended in the general population (level A). There is also no evidence to support systematic screening in a population with genetic risk factors (endometriosis in a relative), or with other clinical risk factors (increased menstrual volume, short cycles, early menarche) (level A). However, it is possible to propose a decision tree for the management of chronic pelvic pain symptoms (dysmenorrhea, dyspareunia, non-menstrual pelvic pain). The search for symptoms suggestive of endometriosis (intense dysmenorrhea [visual analogue scale >7/10, frequent abstention, resistance to level 1 analgesics], infertility) should be systematic. The search for localizing symptoms of deep endometriosis (deep dyspareunia, cyclic defecation pain, cyclic urinary signs) enables to orient the patient to second line evaluation. We propose a decision tree for second and third line evaluations, according to the suspicion and/or the discovery of deep lesions with specific locations, or the suspicion of superficial lesions.
在本章中,我们研究了在普通人群以及目标人群中筛查子宫内膜异位症的可能性。然后,我们针对初级保健和二级保健提出了决策树。目前,文献中没有足够的数据来开发或组织针对子宫内膜异位症的筛查测试。不建议在普通人群中进行子宫内膜异位症筛查(A级)。也没有证据支持对有遗传风险因素(亲属患有子宫内膜异位症)或其他临床风险因素(月经量增加、月经周期短、初潮早)的人群进行系统筛查(A级)。然而,有可能针对慢性盆腔疼痛症状(痛经、性交困难、非经期盆腔疼痛)的管理提出一个决策树。应系统地寻找提示子宫内膜异位症的症状(严重痛经[视觉模拟评分>7/10、频繁缺勤、对1级镇痛药耐药]、不孕)。寻找深部子宫内膜异位症的定位症状(深部性交困难、周期性排便疼痛、周期性泌尿系统症状)有助于引导患者进行二线评估。根据对特定部位深部病变的怀疑和/或发现,或对浅表病变的怀疑,我们提出了二线和三线评估的决策树。